Consensus Statements on the Clinical Practice for Patients With Fontan‐Associated Liver Disease
Hepatology Research · 16.11.2026
DOI: 10.1111/hepr.70241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 16.11.2026. Verfasst von Tatsuya Kanto und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Research Center for Hepatitis and Immunology, National Institute of Global Health and Medicine, Japan Institute for Health Security, Chiba, Japan. Die Arbeit nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Institute for Health Security, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
The Fontan procedure has been transformative for patients with univentricular physiology. By using a single ventricle as the systemic pump and relying on passive venous return to drive pulmonary circulation, Fontan circulation alleviates cyanosis and heart failure, allowing children to engage in normal activities during school and adolescence. Nevertheless, Fontan circulation is characterized by chronically elevated systemic venous pressure, which leads to systemic venous congestion and long‐term multiorgan effects. Fontan‐associated liver disease (FALD) is now recognized as a major long‐term complication. Approximately 50% of patients develop hepatic abnormalities within 10–20 years after surgery, and some progress to cirrhosis and hepatocellular carcinoma (HCC). Despite this risk, strategies to identify individuals at high risk for early HCC and to provide better prognostic information remain limited. This article compiles knowledge from congenital heart disease specialists and hepatologists on FALD, including areas where evidence is limited. By facilitating early diagnosis, structured follow‐up, and multidisciplinary management of FALD, this initiative aims to improve outcomes, build a nationwide clinical experience, and ultimately support the development of formal, evidence‐based guidelines for FALD management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Research Center for Hepatitis and Immunology, National Institute of Global Health and Medicine, Japan Institute for Health Security, Chiba, Japan.
- Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
- Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
- Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.
- Department of Diagnostic Pathology, Kurume University Hospital, Fukuoka, Japan.
ORCID-Profile: Teiji Akagi, Satoko Ohfuji, Ryotaro Sakamori, Tomomi Kogiso, Tomoharu Yoshizumi, Jun Muneuchi, Norihisa Toh
Förderung
- Japan Institute for Health Security
- Ministry of Health, Labour and Welfare
Zitieren
APA
Kanto, T., Akagi, T., Yamagishi, H., Ohfuji, S., Tokuhara, D., Kusano, H., Sakamori, R., Tateishi, R., Kogiso, T., Yoshizumi, T., Muneuchi, J., Toh, N., Inuzuka, R., & Ohuchi, H. (2026). Consensus Statements on the Clinical Practice for Patients With Fontan‐Associated Liver Disease. Hepatology Research. https://doi.org/10.1111/hepr.70241
Vancouver
Kanto T, Akagi T, Yamagishi H, Ohfuji S, Tokuhara D, Kusano H, et al. Consensus Statements on the Clinical Practice for Patients With Fontan‐Associated Liver Disease. Hepatology Research. 2026. doi:10.1111/hepr.70241
BibTeX
@article{Kanto2026,
author = {Kanto, Tatsuya and Akagi, Teiji and Yamagishi, Hiroyuki and Ohfuji, Satoko and Tokuhara, Daisuke and Kusano, Hironori and Sakamori, Ryotaro and Tateishi, Ryosuke and Kogiso, Tomomi and Yoshizumi, Tomoharu and Muneuchi, Jun and Toh, Norihisa and Inuzuka, Ryo and Ohuchi, Hideo},
title = {Consensus Statements on the Clinical Practice for Patients With Fontan‐Associated Liver Disease},
journal = {Hepatology Research},
year = {2026},
doi = {10.1111/hepr.70241}
}
EUVIMED